420 related articles for article (PubMed ID: 34661731)
1. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
Sardana A; Singh K; Singh A; Singh VK
Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
[TBL] [Abstract][Full Text] [Related]
3. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
Tang L; Luo D; Qiu Q; Xu GT; Zhang J
Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
[TBL] [Abstract][Full Text] [Related]
4. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.
Kaya M; Atas F; Kocak N; Ozturk T; Ayhan Z; Kaynak S
Curr Eye Res; 2023 May; 48(5):498-505. PubMed ID: 36629472
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Macular Edema With and Without Subfoveal Neuroretinal Detachment: Two Different Morphologic and Functional Entities.
Vujosevic S; Torresin T; Berton M; Bini S; Convento E; Midena E
Am J Ophthalmol; 2017 Sep; 181():149-155. PubMed ID: 28687219
[TBL] [Abstract][Full Text] [Related]
8. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
9. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
Yanxia C; Xiongyi Y; Min F; Xiaoyun K
Ophthalmic Res; 2024; 67(1):96-106. PubMed ID: 38211574
[TBL] [Abstract][Full Text] [Related]
10. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
11. Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study.
Saurabh K; Roy R; Herekar S; Mistry S; Choudhari S
Indian J Ophthalmol; 2021 Nov; 69(11):3203-3206. PubMed ID: 34708773
[TBL] [Abstract][Full Text] [Related]
12. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
13. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of retinal inflammatory biomarkers after intravitreal steroid implant and Ranibizumab injection in diabetic macular edema.
Muftuoglu IK; Tokuc EO; Sümer F; Karabas VL
Eur J Ophthalmol; 2022 May; 32(3):1627-1635. PubMed ID: 34219488
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
Wang XN; Cai X; He S; Zhang X; Wu Q
Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography biomarkers in patients with macular edema secondary to retinal vein occlusion treated with dexamethasone implant.
Castro-Navarro V; Monferrer-Adsuara C; Navarro-Palop C; Montero-Hernández J; Cervera-Taulet E
BMC Ophthalmol; 2022 Apr; 22(1):191. PubMed ID: 35473615
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study.
Zhu R; Xiao S; Zhang W; Li J; Yang M; Zhang Y; Gu X; Yang L
BMC Ophthalmol; 2022 Aug; 22(1):352. PubMed ID: 36038824
[TBL] [Abstract][Full Text] [Related]
19. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography.
Mao J; Zhang S; Zheng Z; Deng X; Liu C; Chen Y; Zhao S; Zhang Y; Shen L
Acta Ophthalmol; 2022 Jun; 100(4):e891-e898. PubMed ID: 34403203
[TBL] [Abstract][Full Text] [Related]
20. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS OF RETINAL HYPERPERMEABILITY AND CHOROIDAL INFLAMMATION AS PREDICTORS OF SHORT-TERM FUNCTIONAL AND ANATOMICAL OUTCOMES IN EYES WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL BEVACIZUMAB.
Mazloumi M; Entezari M; Samadikhadem S; Ramezani A; Nikkhah H; Arevalo JF
Retina; 2022 Apr; 42(4):760-766. PubMed ID: 35350050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
